BR0010863A - Il-8 receptor antagonists - Google Patents
Il-8 receptor antagonistsInfo
- Publication number
- BR0010863A BR0010863A BR0010863-4A BR0010863A BR0010863A BR 0010863 A BR0010863 A BR 0010863A BR 0010863 A BR0010863 A BR 0010863A BR 0010863 A BR0010863 A BR 0010863A
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- phenylureas
- chemokine
- interleukin
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
Abstract
"ANTAGONISTAS DE RECEPTORES DE IL-8". Esta invenção refere-se ao uso inovador de fenil-uréias no tratamento de estados doentios mediados pela quimiocina, Interleucina-8 (IL-8)."IL-8 RECEPTOR ANTAGONISTS". This invention relates to the innovative use of phenylureas in the treatment of ill states mediated by the chemokine, Interleukin-8 (IL-8).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13666599P | 1999-05-28 | 1999-05-28 | |
PCT/US2000/014660 WO2000072840A1 (en) | 1999-05-28 | 2000-05-26 | Il-8 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0010863A true BR0010863A (en) | 2002-02-19 |
Family
ID=22473833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0010863-4A BR0010863A (en) | 1999-05-28 | 2000-05-26 | Il-8 receptor antagonists |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1180025A4 (en) |
JP (1) | JP2003500443A (en) |
KR (1) | KR20020016806A (en) |
CN (1) | CN1352554A (en) |
AR (1) | AR029361A1 (en) |
AU (1) | AU766999B2 (en) |
BR (1) | BR0010863A (en) |
CA (1) | CA2374295A1 (en) |
CO (1) | CO5170528A1 (en) |
CZ (1) | CZ20014246A3 (en) |
HK (1) | HK1045256A1 (en) |
HU (1) | HUP0201302A3 (en) |
IL (1) | IL146053A0 (en) |
MX (1) | MXPA01012267A (en) |
NO (1) | NO20015774D0 (en) |
NZ (1) | NZ514728A (en) |
PL (1) | PL351947A1 (en) |
TR (1) | TR200103354T2 (en) |
WO (1) | WO2000072840A1 (en) |
ZA (1) | ZA200109627B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1202718A2 (en) * | 1999-07-21 | 2002-05-08 | Kadmus Pharmaceuticals, Inc. | Substituted guanidines for the treatment of cancer and pain |
EP1413302A3 (en) * | 1999-07-21 | 2004-05-12 | Kadmus Pharmaceuticals, Inc. | Substituted guanidines for the treatment of pain |
US6875759B1 (en) | 1999-07-21 | 2005-04-05 | Kadmus Pharmaceuticals | Substituted guanidines and the use thereof |
EP1395548A1 (en) | 2001-02-26 | 2004-03-10 | 4Sc Ag | Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
DE10109204A1 (en) * | 2001-02-26 | 2002-09-19 | 4Sc Ag | Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
EP1622611A1 (en) | 2003-05-01 | 2006-02-08 | F. Hoffmann-La Roche Ag | Imidazolin-2-ylaminophenyl amides as ip antagonists |
CN101531621B (en) * | 2009-04-14 | 2012-08-15 | 厦门康奥克科技有限公司 | Method for preparing guanidine compound |
JP2021501198A (en) * | 2017-10-27 | 2021-01-14 | トランスフュージョン ヘルス,リミティド ライアビリティ カンパニー | Compositions and Methods for Proliferating Hematopoietic Stem Cells Using Fluorene Derivatives |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US605977A (en) * | 1898-06-21 | Bruno richard seifert | ||
US1953494A (en) * | 1926-08-26 | 1934-04-03 | Ig Farbenindustrie Ag | Process of preparing substituted guanidines |
US3914306A (en) * | 1972-09-22 | 1975-10-21 | Rorer Inc William H | Guanidines |
US5696290A (en) * | 1994-09-12 | 1997-12-09 | Monsanto Company | Synthesis of penta-substituted guanidines |
JPH11503110A (en) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | IL-8 receptor antagonist |
AR008290A1 (en) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | NEW COMPOUNDS CONTAINING GUANIDINE USEFUL AS ANTAGONISTS OF IL-8 RECEPTORS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND PROCEDURE FOR THE PREPARATION OF INTERMEDIARIES. |
WO2000072800A2 (en) * | 1999-05-28 | 2000-12-07 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
UY26627A1 (en) * | 2000-03-24 | 2001-09-28 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
-
2000
- 2000-05-24 CO CO00038191A patent/CO5170528A1/en not_active Application Discontinuation
- 2000-05-24 AR ARP000102556A patent/AR029361A1/en unknown
- 2000-05-26 IL IL14605300A patent/IL146053A0/en unknown
- 2000-05-26 TR TR2001/03354T patent/TR200103354T2/en unknown
- 2000-05-26 EP EP00936368A patent/EP1180025A4/en not_active Withdrawn
- 2000-05-26 CZ CZ20014246A patent/CZ20014246A3/en unknown
- 2000-05-26 CN CN00808133A patent/CN1352554A/en active Pending
- 2000-05-26 WO PCT/US2000/014660 patent/WO2000072840A1/en not_active Application Discontinuation
- 2000-05-26 KR KR1020017015176A patent/KR20020016806A/en not_active Application Discontinuation
- 2000-05-26 JP JP2000620952A patent/JP2003500443A/en not_active Withdrawn
- 2000-05-26 BR BR0010863-4A patent/BR0010863A/en not_active IP Right Cessation
- 2000-05-26 PL PL00351947A patent/PL351947A1/en not_active Application Discontinuation
- 2000-05-26 MX MXPA01012267A patent/MXPA01012267A/en unknown
- 2000-05-26 NZ NZ514728A patent/NZ514728A/en not_active Application Discontinuation
- 2000-05-26 CA CA002374295A patent/CA2374295A1/en not_active Abandoned
- 2000-05-26 HU HU0201302A patent/HUP0201302A3/en unknown
- 2000-05-26 AU AU51690/00A patent/AU766999B2/en not_active Ceased
-
2001
- 2001-11-22 ZA ZA200109267A patent/ZA200109627B/en unknown
- 2001-11-27 NO NO20015774A patent/NO20015774D0/en not_active Application Discontinuation
-
2002
- 2002-07-18 HK HK02105335.1A patent/HK1045256A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CO5170528A1 (en) | 2002-06-27 |
HUP0201302A2 (en) | 2002-12-28 |
AU5169000A (en) | 2000-12-18 |
ZA200109627B (en) | 2002-11-28 |
EP1180025A1 (en) | 2002-02-20 |
HUP0201302A3 (en) | 2003-02-28 |
MXPA01012267A (en) | 2002-07-30 |
NO20015774L (en) | 2001-11-27 |
CA2374295A1 (en) | 2000-12-07 |
JP2003500443A (en) | 2003-01-07 |
NZ514728A (en) | 2004-04-30 |
KR20020016806A (en) | 2002-03-06 |
HK1045256A1 (en) | 2002-11-22 |
CN1352554A (en) | 2002-06-05 |
CZ20014246A3 (en) | 2002-05-15 |
TR200103354T2 (en) | 2002-06-21 |
PL351947A1 (en) | 2003-07-14 |
EP1180025A4 (en) | 2002-08-28 |
WO2000072840A1 (en) | 2000-12-07 |
NO20015774D0 (en) | 2001-11-27 |
AU766999B2 (en) | 2003-10-30 |
AR029361A1 (en) | 2003-06-25 |
IL146053A0 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9612779A (en) | Antagonists to the il-8 receptor | |
BR0110968A (en) | Il-8 Receptor Antagonists | |
BR9916159A (en) | Hydroxy-diphenylurea sulphonamides as antagonists of il-8 receptors | |
TR199900318T2 (en) | IL-8 receptor antagonists. | |
EP1129089A4 (en) | Spiro-indolines as y5 receptor antagonists | |
PT1047781E (en) | IL-18 RECEPTORS | |
ATE346869T1 (en) | AGONISTIC ANTIBODIES AGAINST TIE2 | |
EP1357909A4 (en) | Il-8 receptor antagonists | |
IT1308657B1 (en) | CCR-3 RECEPTOR ANTAGONISTS II. | |
IT1318319B1 (en) | RUBBER COMPOSITION, PROCEDURE TO PRODUCE THE SAME AND SLEEVE USING THE RUBBER COMPOSITION. | |
BR0010843A (en) | Il-8 receptor antagonists | |
BR0108866A (en) | Il-8 Receptor Antagonists | |
WO2001068568A3 (en) | Il-8 receptor antagonists | |
BR0010863A (en) | Il-8 receptor antagonists | |
WO2001068569A3 (en) | Il-8 receptor antagonists | |
AP1548A (en) | Il-8 Receptor Antagonists. | |
NZ514696A (en) | IL-8 receptor antagonists | |
WO2000072800A3 (en) | Il-8 receptor antagonists | |
WO2001076530A3 (en) | Il-8 receptor antagonists | |
WO2001064165A3 (en) | Il-8 receptor antagonists | |
AP2002002606A0 (en) | IL-8 receptor antagonists. | |
WO2001068033A3 (en) | Il-8 receptor antagonists | |
MXPA03000500A (en) | Use of il-8 receptor antagonists in the treatment of virus infections. | |
AR002996A1 (en) | Isoxazolines enhanced fibrinogen receptor antagonists. | |
BR0010985A (en) | Il-8 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8O E 9O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |